Sponsor Dossier
Sandoz
Sponsor Dossier for Sandoz. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABIRATERONE SANDOZ
- Brand: ACICLOVIR SANDOZ
- Brand: ACLASTA
- Brand: AFONAISE
- Brand: AFQLIR
- Brand: ALENDRONATE
- Brand: ALLOPURINOL SANDOZ
- Brand: ALPRAZOLAM SANDOZ
- Device (sponsor): Cartridge-accepting autoinjector, mechanical
- Device (sponsor): Basic growth hormone pen, replaceable-cartridge
About
Sandoz is an Australian Private Company with ABN 60075449553, registered in NSW and currently active.
Portfolio
Sandoz has 205 brands on the ARTG, of which 172 are indexable and 165 carry a Product Information document. 153 brands are PBS-listed, 17 have a PBAC outcome on record, and 10 have an AusPAR on record. Notable brands include ABIRATERONE SANDOZ, ACICLOVIR SANDOZ, ACLASTA, AFONAISE, AFQLIR, ALENDRONATE, ALLOPURINOL SANDOZ, ALPRAZOLAM SANDOZ, AMBRISENTAN SANDOZ, AMIODARONE, AMLODIPINE SANDOZ, AMOXYCILLIN SANDOZ.
Therapeutic focus
— Cardiology: 35 brands — Oncology: 33 brands — Infectious Disease: 25 brands — Psychiatry: 20 brands — Pain Management: 12 brands — Neurology: 12 brands — Endocrinology: 11 brands — Gastroenterology: 10 brands — Musculoskeletal: 10 brands — Immunology: 7 brands — Reproductive Health: 7 brands — Respiratory: 6 brands — Haematology: 4 brands — Ophthalmology: 4 brands — Other: 3 brands — Dermatology: 3 brands — Complementary Medicine: 2 brands — Renal: 1 brand
PBS footprint
153 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-03-01, across 17 brands with a PBAC outcome on record. The latest AusPAR is 2025-11-12, across 10 brands with an AusPAR on record.